122 related articles for article (PubMed ID: 6343295)
1. Effects of treatment with muramyl dipeptide on resistance to Mycobacterium leprae and Mycobacterium marinum infection in mice.
Krahenbuhl JL; Humphres RC
Immunopharmacology; 1983 Apr; 5(4):329-39. PubMed ID: 6343295
[TBL] [Abstract][Full Text] [Related]
2. Analogy of Mycobacterium marinum disease to Mycobacterium leprae infection in footpads of mice.
Ng H; Jacobsen PL; Levy L
Infect Immun; 1973 Dec; 8(6):860-7. PubMed ID: 4594116
[TBL] [Abstract][Full Text] [Related]
3. Effects of Propionibacterium acnes treatment on the course of Mycobacterium leprae infection in mice.
Krahenbuhl JL; Humphres RC; Henika PC
Infect Immun; 1982 Jul; 37(1):183-8. PubMed ID: 7049949
[TBL] [Abstract][Full Text] [Related]
4. The presence of systemic and local activated macrophages in mice infected in the foot pad with Mycobacterium leprae and M. marinum.
Krahenbuhl JL; Welch TM; Levy L
Int J Lepr Other Mycobact Dis; 1976; 44(1-2):206-15. PubMed ID: 776858
[TBL] [Abstract][Full Text] [Related]
5. Protective effect of muramyl dipeptide analogs in combination with trehalose dimycolate against aerogenic influenza virus and Mycobacterium tuberculosis infections in mice.
Masihi KN; Brehmer W; Lange W; Ribi E; Schwartzman S
J Biol Response Mod; 1984 Dec; 3(6):663-71. PubMed ID: 6439830
[TBL] [Abstract][Full Text] [Related]
6. Human NOD2 Recognizes Structurally Unique Muramyl Dipeptides from Mycobacterium leprae.
Schenk M; Mahapatra S; Le P; Kim HJ; Choi AW; Brennan PJ; Belisle JT; Modlin RL
Infect Immun; 2016 Sep; 84(9):2429-38. PubMed ID: 27297389
[TBL] [Abstract][Full Text] [Related]
7. Effects of treatment with muramyl dipeptide and certain of its analogs on resistance to Listeria monocytogenes in mice.
Humphres RC; Henika PR; Ferraresi RW; Krahenbuhl JL
Infect Immun; 1980 Nov; 30(2):462-6. PubMed ID: 7439991
[TBL] [Abstract][Full Text] [Related]
8. Immunity to Mycobacterium leprae infections in mice stimulated by M. leprae, BCG, and graft-versus-host reactions.
Shepard CC; Van Landingham R; Walker LL
Infect Immun; 1976 Oct; 14(4):919-28. PubMed ID: 11189
[TBL] [Abstract][Full Text] [Related]
9. Resistance to mycobacteria in mice treated with fractionated total lymphoid irradiation (TLI) and in mice reconstituted with allogenic bone marrow cells following radiotherapy.
Mor N; Lutsky I; Weiss L; Morecki S; Slavin S
Int J Radiat Oncol Biol Phys; 1985 Jan; 11(1):79-85. PubMed ID: 3155713
[TBL] [Abstract][Full Text] [Related]
10. The effect of body temperature and cell-mediated immunity on the growth of Mycobacterium marinum and Mycobacterium leprae in mice.
Lancaster RD; Colston MJ; Hilson GR; Turner SM
J Med Microbiol; 1981 Nov; 14(4):493-500. PubMed ID: 7031255
[TBL] [Abstract][Full Text] [Related]
11. Growth of Mycobacterium leprae and M. marinum in congenitally athymic (nude) mice.
Colston MJ; Hilson GR
Nature; 1976 Jul; 262(5567):399-401. PubMed ID: 785274
[No Abstract] [Full Text] [Related]
12. Evaluation of the immune response in mice infected with Mycobacterium marinum.
Navalkar RG; Patel PJ
Int J Lepr Other Mycobact Dis; 1977; 45(3):228-34. PubMed ID: 336554
[TBL] [Abstract][Full Text] [Related]
13. Reversal of T cell anergy in leprosy patients: in vitro presentation with Mycobacterium leprae antigens using murabutide and Trat peptide in liposomal delivery.
Sridevi K; Khanna N; Chattree V; Pal PC; Haq W; Rao DN
Int Immunopharmacol; 2003 Nov; 3(12):1589-600. PubMed ID: 14555284
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of host resistance against Trypanosoma cruzi infection by the immunoregulatory agent muramyl dipeptide.
Kireszenbaum F; Ferraresi RW
Infect Immun; 1979 Jul; 25(1):273-8. PubMed ID: 113344
[TBL] [Abstract][Full Text] [Related]
15. A dual effect of tilorone on multiplication of Mycobacterium leprae in mice.
Levy L; Aizer F
Agents Actions; 1984 Oct; 15(3-4):398-402. PubMed ID: 6395678
[TBL] [Abstract][Full Text] [Related]
16. Development of a mouse food pad model for detection of sub clinical leprosy.
Lahiri R; Randhawa B; Franken KL; Duthie MS; Spencer JS; Geluk A; Krahenbuhl JL
Lepr Rev; 2011 Dec; 82(4):432-44. PubMed ID: 22439282
[TBL] [Abstract][Full Text] [Related]
17. Effect of MDP-Lys(L18) as a mucosal immunoadjuvant on protection of mucosal infections by Sendai virus and rotavirus.
Fukushima A; Yoo YC; Yoshimatsu K; Matsuzawa K; Tamura M; Tono-oka S; Taniguchi K; Urasawa S; Arikawa J; Azuma I
Vaccine; 1996 Apr; 14(6):485-91. PubMed ID: 8782344
[TBL] [Abstract][Full Text] [Related]
18. Effect of muramyl dipeptide and its stearoyl derivatives on resistance to Sendai virus infection in mice.
Ishihara C; Hamada N; Yamamoto K; Iida J; Azuma I; Yamamura Y
Vaccine; 1985 Dec; 3(5):370-4. PubMed ID: 2417426
[TBL] [Abstract][Full Text] [Related]
19. Protection of mice by intraperitoneal vaccination against challenge in the foot pad with Mycobacterium marinum.
Ng H; Welch TM; Baras M; Levy L
Isr J Med Sci; 1980 Dec; 16(12):849-52. PubMed ID: 7451112
[TBL] [Abstract][Full Text] [Related]
20. Relation of infection to tissue temperature in mice infected with Mycobacterium marinum and Mycobacterium leprae.
Shepard CC; Habas JA
J Bacteriol; 1967 Mar; 93(3):790-6. PubMed ID: 5337835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
